Active Not Recruiting NA INTERVENTIONAL 2-arm NCT03669432

To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer. (THYRO-RT)

Phase II Randomized Controlled Trial Of Postoperative Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Thyroid Cancers.

Sponsor: Department of Atomic Energy

Conditions Radiation Toxicity Thyroid Cancer Stage IV

Interventions Intensity Modulated Radiotherapy Surgery alone

Updated 7 times since 2018 Last updated: Apr 29, 2022 Started: Jul 31, 2013 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Radiation Toxicity and Thyroid Cancer Stage IV and is currently ongoing. Department of Atomic Energy leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Jun 2022 — Jul 2024 [monthly]

Active Not Recruiting NA

Status: Unknown Status → Active Not Recruiting
Apr 2022 — Jun 2022 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Apr 2022 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Oct 2018 — Apr 2020 [monthly]

Recruiting NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Department of Atomic Energy
Tata Memorial Hospital

Data source: Tata Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India